Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+47.4%
5Y CAGR+35.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+47.4%/yr
Annual compound
5Y CAGR
+35.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 122.87% |
| 2024 | 82.49% |
| 2023 | -16.48% |
| 2022 | 38.36% |
| 2021 | 12.40% |
| 2020 | 26.91% |
| 2019 | -7.70% |
| 2018 | -31.60% |
| 2017 | -45.43% |
| 2016 | -23.00% |